Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
28 Apr, 2026, 04.00 AM IST
Dr Reddy’s shares fall 2% after Goldman Sachs downgrades, Citi turns cautiousDr Reddy’s shares fell after Goldman Sachs and Citigroup turned cautious, citing limited growth visibility, pipeline concerns and valuation...
24 Apr, 2026, 10.35 AM IST
Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
10 Apr, 2026, 09.49 AM IST
Tariff threat ain't over yet! Sun Pharma, other pharma stocks plunge up to 6%Pharma stocks fell after reports that the Trump administration may impose tariffs—potentially up to 100%—on drugmakers not ensuring low pri...
02 Apr, 2026, 12.13 PM IST
Stocks in news: Vedanta, Tata Capital, Tata Motors PV, Godrej Properties, Dr Reddy'sMarkets ended marginally higher after a volatile session, with analysts advising caution. Several companies like Vedanta, Tata Motors PV, a...
23 Mar, 2026, 06.28 AM IST
Aurobindo Pharma plunges over 14% after ED arrests company director“The company learnt that P Sarath Chandra Reddy, whole-time director/ promoter group of the company, has been arrested by the Enforcement D...
10 Nov, 2022, 04.48 PM IST
Pharma is in focus but there is no valuation comfort: Prabhudas Lilladher‘We have a buy on Dr Reddy’s and Lupin. Dr Reddy’s definitely has a positive but the valuation remains very challenging after this recent r...
18 Sep, 2020, 05.50 PM IST
Licence to sell cancer drug biggest opportunity for Dr Reddy’s in US market: Nirmal Bang‘On a very conservative basis, the drug can add about $300 million to their sales in FY23-FY24.’
18 Sep, 2020, 11.44 AM IST
Market Now: Sun Pharma, Cipla drag Nifty Pharma index downBharat Petroleum, Tata Motors, Sun Pharma and Hero MotoCorp were the top drags in the Nifty index.
20 Sep, 2017, 10.57 AM IST
Market Now: Sun TV, Infosys among most active stocks in value termsPharma, realty and media indices surged over 2 per cent on NSE.
01 Sep, 2017, 10.37 AM IST
Put trailing stop losses in place for midcap stocks: Guarang ShahWhen the lesser-known names start reacting on the negative side, then there would be a bit of deeper cut, says Shah in an interview with ET...
30 Nov, 2015, 03.42 PM IST
Avoid Ranbaxy after USFDA revokes approval; prefer Dr. Reddy's from the pharma space: Mayuresh Joshi"Dr. Reddy’s has got and the valuation comfort that one drives with, Dr. Reddy’s becomes our preferred pick at this point of time."
07 Nov, 2014, 10.15 AM IST
- Short-term outlook positive for pharma stocks: JV Capital Services
Buy with dips until the momentum is broken but for sure, short-term outlook is still reasonably positive for these stocks.
19 Jul, 2012, 01.42 PM IST
- Jaganmohan Reddy's arrest pulls down Ramky Infrastructure stock by 15 per cent
On Monday, Ramky Infrastructure shares fell to a new 52-week low of 118.10 on news reports that the company may have made wrongful gains wh...
29 May, 2012, 02.56 AM IST
- Avoid Ranbaxy; bullish on Sun Pharma, Cipla: Ashwani Gujral
I would avoid Ranbaxy for the moment as it is too much news driven.
30 Nov, 2011, 10.41 AM IST
- Dr. Reddy Laboratories can get back to Rs 1,800-1,850: Ashwani Gujral
Dr. Reddy is probably the strongest in the pharma lot. It has corrected towards Rs 1,470-1,480, and yesterday was a good day in Dr. Reddy.
08 Mar, 2011, 10.22 AM IST
- 'Pharma space looks exciting'
Ashit Suri, Fundamental Research Analyst, JV Capital Services, spoke to ET Now on pharma stocks prospects. Excerpts:
19 Mar, 2010, 04.28 PM IST